Zentek completes $2.48 million private placement of units
Get Alerts ZTEK Hot Sheet
Join SI Premium – FREE
Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) completed a non-brokered private placement raising gross proceeds of $2,479,227 through the issuance of 2,338,893 units priced at $1.06 per unit.
Each unit includes one common share, one-half of a Series A warrant, and one-half of a Series B warrant. The Series A warrants allow holders to purchase common shares at $1.50 until October 22, 2027, while Series B warrants enable purchases at $2.00 until October 22, 2028.
The company can accelerate the Series A warrant expiry if shares trade at $2.00 or higher for 10 consecutive trading days after the four-month hold period. Series B warrants may be accelerated if shares reach $3.00 for 10 consecutive trading days after six months from closing.
Zentek paid finder fees totaling $35,429.33 and issued 33,424 finder warrants exercisable at $1.06 per unit until October 22, 2027. All securities are subject to a four-month-plus-one-day hold period.
Company directors participated in the offering, constituting a related party transaction under securities regulations. The transaction qualifies for exemptions from formal valuation and minority shareholder approval requirements as the consideration does not exceed 25% of the company's market capitalization.
The Guelph, Ontario-based company plans to use proceeds for general and administrative corporate purposes. Zentek operates as an intellectual property development and commercialization company with ISO 13485:2016 certification, focusing on products for commercial partners in filtration and diagnostic markets.
You May Also Be Interested In
- Waymo Explores Split With Uber - FT
- CalciMedica (CALC) files for 56.02M share offering by selling stockholders
- Silo Pharma, Inc. (SILO) files for 1.91M share offering by selling stockholders
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share